SIREN : 810246686
FINANCIERE CLASQUIN EUROMED is a French company founded 11 years ago, specialized in the sector Activités des sociétés holding. Based in LYON (69006), this company of category ETI shows in 2024 a revenue of 179 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179 235 € | 154 784 € | 88 928 € | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 381 847 € | 316 830 € | 1 912 147 € | 1 949 868 € | -52 952 € | 1 643 504 € | 1 532 071 € | 2 414 755 € | 1 409 050 € |
| EBITDA | 24 876 € | -79 881 € | 23 139 € | -3 964 € | -6 374 € | -2 511 € | -891 € | -3 133 € | -12 580 € |
| Net margin | 213.0% | 204.7% | 2150.2% | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, FINANCIERE CLASQUIN EUROMED achieves revenue of 179 k€. Over the period 2022-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +42.0%. Vs 2023, growth of +16% (155 k€ -> 179 k€). After deducting consumption (0 €), gross margin stands at 179 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 25 k€, representing 13.9% of revenue. Positive scissor effect: EBITDA margin improves by +65.5 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 382 k€, i.e. 213.0% of revenue. This profit can be retained or distributed to shareholders.
179 235 €
179 235 €
24 876 €
-68 087 €
381 847 €
13.9%
The debt ratio (= Financial debt / Equity x 100) stands at 96%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 29.0 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 303.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
95.762%
50.834%
303.816%
28.963
86.2%
In 2024, the debt ratio of FINANCIERE CLASQUIN EUROMED (95.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of FINANCIERE CLASQUIN EUROMED (50.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of FINANCIERE CLASQUIN EUROMED (28.96) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 374.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 3233.4x. Operating income very largely covers interest expenses: high safety margin.
374.479
3233.402
In 2024, the liquidity ratio of FINANCIERE CLASQUIN EUROMED (374.48) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of FINANCIERE CLASQUIN EUROMED (3233.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 176 days. Excellent situation: suppliers finance 174 days of the operating cycle (retail model). WCR is negative (-73 days): operations structurally generate cash.
-36 458 €
2 j
176 j
0 j
-73 j
Based on 54 transactions of similar company sales
in 2024,
the value of FINANCIERE CLASQUIN EUROMED is estimated at
203 303 €
(range 100 987€ - 711 651€).
With an EBITDA of 24 876€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare FINANCIERE CLASQUIN EUROMED with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of FINANCIERE CLASQUIN EUROMED in 2024 is 179 k€.
Yes, FINANCIERE CLASQUIN EUROMED generated a net profit of 382 k€ in 2024.
The headquarters of FINANCIERE CLASQUIN EUROMED is located in LYON (69006), in the department Rhone.
The tax return of FINANCIERE CLASQUIN EUROMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
FINANCIERE CLASQUIN EUROMED operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.